🔴 Femasys is trading 6% down with no clear catalyst identified

Femasys is trading 6.00% down at $1.88, with no clear company-specific catalyst identified for the October 12 move.

• The October 8 announcement about exhibiting at the ASRM congress concerns a future event and does not establish a reason for the decline.
• Available market context was nearly flat, while biotech coverage pointed to mixed sector performance; neither clearly explains the drop.